{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:35:07Z","timestamp":1787960107248,"version":"build-2784847793"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1111\/jcpt.13316","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T14:54:41Z","timestamp":1606316081000},"page":"524-527","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["High\u2010level ceftaroline resistance in a paediatric patient with invasive methicillin\u2010resistant\n            <i>Staphylococcus aureus<\/i>\n            infection without previous ceftaroline exposure"],"prefix":"10.1155","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-6801","authenticated-orcid":false,"given":"Chelsea L.","family":"Ferguson","sequence":"first","affiliation":[{"name":"Department of Pharmacy Orlando Health Arnold Palmer Hospital for Children Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-6522","authenticated-orcid":false,"given":"Mallory C.","family":"Cowart","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Orlando Health Arnold Palmer Hospital for Children Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Jordan\u2010Villegas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Orlando Health Arnold Palmer Hospital for Children Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Laham","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Orlando Health Arnold Palmer Hospital for Children Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr095"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0144-8"},{"key":"e_1_2_5_4_1","volume-title":"Teflaro [package insert]","year":"2010"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir034"},{"issue":"6","key":"e_1_2_5_6_1","first-page":"476","article-title":"ceftaroline fosamil use in 2 pediatric patients with invasive methicillin\u2010resistant Staphylococcus aureus Infections","volume":"20","author":"Williams AW","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"e_1_2_5_7_1","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jcf.2017.10.010","article-title":"Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis","volume":"17","author":"Barksy EE","year":"2018","journal-title":"J Cyst Fibros"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001160"},{"issue":"60","key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/PCC.0000000000001497","article-title":"Ceftaroline for suspected or confirmed invasive methicillin\u2010resistant Staphylococcus aureus: a pharmacokinetic case series","volume":"19","author":"Cies JJ","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks006"},{"issue":"1","key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.3390\/antibiotics8010030","article-title":"A mini\u2010review on ceftaroline in bacteremia patients with methicillin\u2010resistant Staphylococcus aureus (MRSA) infections","volume":"8","author":"Lounsbury N","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016664361"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0449-9"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001171"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03622-14"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw001"},{"issue":"3","key":"e_1_2_5_17_1","doi-asserted-by":"crossref","first-page":"e01235","DOI":"10.1128\/AAC.01235-16","article-title":"Ceftaroline\u2010resistant, daptomycin\u2010tolerant, and heterogeneous vancomycin\u2010intermediate methicillin\u2010resistant Staphylococcus aureus causing infective endocarditis","volume":"61","author":"Nigo M","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_5_18_1","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"CLSI","year":"2020"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm150"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000307"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001477"},{"issue":"1","key":"e_1_2_5_22_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13756-020-00829-z","article-title":"Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime\u2010avibactam: a surveillance study from the ATLAS program (2012\u20132016)","volume":"9","author":"Zhang H","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"e_1_2_5_23_1","first-page":"112","article-title":"Resistance to ceftaroline \u2013 2018 review","volume":"8","author":"Slusarczyk R","year":"2018","journal-title":"Euro J Biol Res"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2019.0130"},{"issue":"4","key":"e_1_2_5_25_1","first-page":"115000","article-title":"Genotypic analysis of Italian MRSA strains exhibiting low\u2010level ceftaroline and ceftobiprole resistance","volume":"96","author":"Bongiorno D","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"e_1_2_5_26_1","doi-asserted-by":"crossref","first-page":"106016","DOI":"10.1016\/j.ijantimicag.2020.106016","article-title":"Susceptibility of Clinical Isolates of Methicillin\u2010Resistant Staphylococcus aureus and Phenotypic Non\u2010extended\u2010spectrum \u0392\u2010lactamase\u2010Producing Klebsiella pneumoniae to Ceftaroline In Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012\u20132018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018\u20132019","volume":"56","author":"Jean SS","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"e_1_2_5_27_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s42003-020-01313-5","article-title":"Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA","volume":"3","author":"Varela MC","year":"2020","journal-title":"Commun Biol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13316","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.13316","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:50Z","timestamp":1671818750000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.13316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/jcpt.13316"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.13316","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"2020-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}